Are atrial myxomas hereditary?

Are Atrial Myxomas Hereditary?

Yes, atrial myxomas can be hereditary, though most cases (approximately 90-95%) are sporadic; the hereditary form accounts for 5-10% of cases and is most commonly associated with Carney complex, an autosomal dominant syndrome caused by PRKAR1A gene mutations 1, 2.

Understanding the Hereditary Pattern

The hereditary form of atrial myxoma follows an autosomal dominant inheritance pattern, meaning:

• A single copy of the mutated gene from one parent is sufficient to cause disease
• Each child of an affected parent has a 50% chance of inheriting the condition
• Both males and females are equally affected
• The condition can be transmitted from either parent, though paternal-to-daughter transmission has been documented 3

Carney Complex: The Primary Hereditary Syndrome

Carney complex accounts for up to two-thirds of all familial cardiac myxomas 4 and is characterized by:

• Genetic basis: 70-80% of cases have pathogenic variants in the PRKAR1A gene 1
• Cardiac manifestations: Cardiac myxomas are among the most common features, particularly in prepubertal patients
• Associated features: Multiple mucocutaneous lesions (lentigines, cutaneous myxomas), endocrine tumors (growth hormone-secreting pituitary tumors, primary pigmented nodular adrenocortical disease), large cell calcifying Sertoli cell tumors, and increased risk of breast cancer in women (mean onset 44.7 years) 1

Critical Clinical Differences Between Sporadic and Hereditary Forms

Hereditary myxomas behave much more aggressively than sporadic cases 2:

Recurrence Risk

• Sporadic myxomas: Rarely recur (1-3% recurrence rate)
• Familial/Carney complex myxomas: High recurrence rates, with second and even third recurrences documented 2, 5
• Recurrence intervals can be as short as 4 months to several years 2, 5

Clinical Presentation

• Multiple chamber involvement: Can affect 3 or 4 cardiac chambers simultaneously or sequentially 2
• Earlier age of onset: Often presents in younger patients
• More aggressive phenotype: Can cause cardioembolic stroke, severe transmitral obstruction with heart failure, infected myxoma, and sudden death 2

Location Patterns

• Both sporadic and familial forms most commonly occur in the left atrium (75-85% of cases) 6
• Familial forms more likely to involve multiple chambers

Genetic Heterogeneity

The hereditary form is genetically heterogeneous 7:

• While PRKAR1A on chromosome 2p is the most common genetic cause
• Other genetic loci can also produce familial atrial myxomas
• This means genetic testing may not identify a mutation in all familial cases

Essential Clinical Management for Hereditary Cases

Surveillance Requirements

Lifelong echocardiographic surveillance is mandatory for:

• All patients with confirmed hereditary myxoma after surgical resection 4
• All first-degree relatives of affected individuals 5, 4

Surveillance should begin at age 5 years for confirmed PRKAR1A pathogenic variant carriers 1, including:

• Regular echocardiography
• Physical examination for cutaneous manifestations
• Biochemical screening for endocrine manifestations
• Scrotal ultrasound in males (for Sertoli cell tumors)

Family Screening

Family screening is strongly recommended 5, 4:

• Genetic testing should be offered to all first-degree relatives
• Even asymptomatic family members require surveillance if they carry the pathogenic variant
• Cascade genetic testing is appropriate once a pathogenic variant is identified in the proband

Advanced Treatment Considerations

For patients with recurrent disease:

• Early recognition and timely intervention are critical 2
• Multiple recurrences may necessitate consideration of advanced strategies, including cardiac transplantation in selected cases with prohibitive surgical risk 2
• The aggressive phenotype can be fatal despite multiple surgical interventions 2

Common Pitfalls to Avoid

1. Assuming all myxomas are sporadic: Failure to recognize familial patterns delays appropriate family screening and surveillance
2. Inadequate follow-up after resection: Even after successful surgery, hereditary cases require lifelong surveillance due to high recurrence risk
3. Missing associated Carney complex features: Look specifically for skin lesions, endocrine abnormalities, and testicular masses that suggest the syndrome
4. Delaying genetic testing: Early genetic confirmation allows for proactive family screening and surveillance initiation

Bottom Line

If a patient presents with atrial myxoma, actively investigate for hereditary features: young age at presentation, family history of cardiac tumors, multiple myxomas, recurrence after resection, or associated features of Carney complex (skin lesions, endocrine tumors). When hereditary myxoma is suspected or confirmed, initiate genetic testing, implement lifelong surveillance, and screen all first-degree relatives 1, 2, 3, 4.